Literature DB >> 29729787

Key Components of Pain Management for Children and Adults with Sickle Cell Disease.

Amanda M Brandow1, Michael R DeBaun2.   

Abstract

Sickle cell disease pain manifests as severe acute pain episodes and a debilitating chronic pain syndrome. Acute pain episodes are the most common reason for health care use; however, acute pain episodes are also frequently managed at home. Chronic pain syndrome develops in 30% to 40% of individuals with sickle cell disease, with an increasing incidence and severity with age. We review the critical aspects of pain management that are integral to the comprehensive approach to sickle cell disease pain and are rooted in the biopsychosocial model. The review focuses on opioid pharmacology and psychosocial comorbidities.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute pain; Anxiety; Chronic pain syndrome; Depression; Opioids; Sickle cell disease; Sleep

Mesh:

Year:  2018        PMID: 29729787      PMCID: PMC6800257          DOI: 10.1016/j.hoc.2018.01.014

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  61 in total

1.  The number of people with sickle-cell disease in the United States: national and state estimates.

Authors:  David C Brousseau; Julie A Panepinto; Mark Nimmer; Raymond G Hoffmann
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

2.  The effect of sleep continuity on pain in adults with sickle cell disease.

Authors:  Gyasi Moscou-Jackson; Patrick H Finan; Claudia M Campbell; Joshua M Smyth; Jennifer A Haythornthwaite
Journal:  J Pain       Date:  2015-04-02       Impact factor: 5.820

3.  Painful episodes in children with sickle cell disease and asthma are temporally associated with respiratory symptoms.

Authors:  Jeffrey Glassberg; John F Spivey; Robert Strunk; Sara Boslaugh; Michael R DeBaun
Journal:  J Pediatr Hematol Oncol       Date:  2006-08       Impact factor: 1.289

4.  The children's depression inventory: a systematic evaluation of psychometric properties.

Authors:  C F Saylor; A J Finch; A Spirito; B Bennett
Journal:  J Consult Clin Psychol       Date:  1984-12

5.  A Prospective Emergency Department Quality Improvement Project to Improve the Treatment of Vaso-Occlusive Crisis in Sickle Cell Disease: Lessons Learned.

Authors:  Paula Tanabe; Caroline E Freiermuth; David M Cline; Susan Silva
Journal:  Jt Comm J Qual Patient Saf       Date:  2017-01-13

6.  IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.

Authors:  Carlton D Dampier; Wally R Smith; Carrie G Wager; Hae-Young Kim; Margaret C Bell; Scott T Miller; Debra L Weiner; Caterina P Minniti; Lakshmanan Krishnamurti; Kenneth I Ataga; James R Eckman; Lewis L Hsu; Donna McClish; Sonja M McKinlay; Robert Molokie; Ifeyinwa Osunkwo; Kim Smith-Whitley; Marilyn J Telen
Journal:  Clin Trials       Date:  2013-04       Impact factor: 2.486

7.  The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease.

Authors:  Stacy S Shord; Larisa H Cavallari; Weihua Gao; Hyun-Young Jeong; Kelly Deyo; Shitalben R Patel; Joseph R Camp; Susan M Labott; Robert E Molokie
Journal:  Eur J Clin Pharmacol       Date:  2009-04-09       Impact factor: 2.953

Review 8.  A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease.

Authors:  Charles R Jonassaint; Victor L Jones; Sharlene Leong; Georita M Frierson
Journal:  Br J Haematol       Date:  2016-03-15       Impact factor: 6.998

9.  The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.

Authors:  David C Brousseau; D Gail McCarver; Amy L Drendel; Karthika Divakaran; Julie A Panepinto
Journal:  J Pediatr       Date:  2007-06       Impact factor: 4.406

10.  Psychological interventions that target sleep reduce pain catastrophizing in knee osteoarthritis.

Authors:  Sheera F Lerman; Patrick H Finan; Michael T Smith; Jennifer A Haythornthwaite
Journal:  Pain       Date:  2017-11       Impact factor: 7.926

View more
  6 in total

1.  Developing an emergency department order set to treat acute pain in sickle cell disease.

Authors:  Yves Duroseau; David Beenhouwer; Michael S Broder; Bonnie Brown; Tartania Brown; Sarah N Gibbs; Kaedrea Jackson; Sally Liang; Melanie Malloy; Marie-Laure Romney; Dana Shani; Jena Simon; Irina Yermilov
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-08-07

Review 2.  A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.

Authors:  Jacob Fiocchi; Ivan Urits; Vwaire Orhurhu; Mariam Salisu Orhurhu; Stephen Giacomazzi; Briggs Hoyt; Alan D Kaye; Rachel J Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

3.  The Role of Cognitive Behavioral Therapy in Opioid Use Reduction in Pediatric Sickle Cell Disease: Protocol for a Systematic Review.

Authors:  Ashaunta T Anderson; Nhu Tran; Kathryn Smith; Lorraine I Kelley-Quon
Journal:  JMIR Res Protoc       Date:  2019-07-17

4.  Self-Report for Assessment of Pain and Quality of Life in Children with Sickle Cell Anemia in a Developing Country.

Authors:  Valeska Brito da Cunha; Camila Freitas de Andrade Rodrigues; Thiago Alves Rodrigues; Eduardo José Silva Gomes de Oliveira; João Batista Santos Garcia
Journal:  J Pain Res       Date:  2020-11-30       Impact factor: 3.133

Review 5.  Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease.

Authors:  Krystal S Plonski
Journal:  Children (Basel)       Date:  2022-07-19

Review 6.  Opioid Use in Patients With Sickle Cell Disease During a Vaso-Occlusive Crisis: A Systematic Review.

Authors:  Hadia Arzoun; Mirra Srinivasan; Isra Sahib; Jack Fondeur; Lisbeth Escudero Mendez; Raneem K Hamouda; Lubna Mohammed
Journal:  Cureus       Date:  2022-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.